文献速递头颈外科

FDG PET/CT参数对手术治疗头颈癌患者预后价值的评估:系统综述

Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2020-01-01

该系统综述纳入36项研究共3585例接受手术治疗的HNSCC患者,评估术前FDG-PET/CT定量参数与总生存、无病生存和远处转移的关联。多数研究显示代谢体积参数(MTV、TLG)为独立预后因素,预后价值高于SUVmax。结论提示体积参数可能有助于识别术后进展高风险患者,但需更大规模分层研究验证。

要点

  • 术前FDG-PET/CT的MTV和TLG在多数研究中为独立预后因素,价值高于SUVmax。
  • 36项研究中32项显示至少一个FDG-PET/CT参数与OS、DFS或DM相关。
  • 纹理指数和放射组学分析证据有限,仅3项研究涉及。

核心结论

  • FDG-PET/CT参数作为接受手术治疗的HNSCC患者OS、DFS和DM的生物标志物可能具有预后价值。
  • 体积参数(MTV和TLG)似乎有助于识别术后疾病进展高风险、可接受早期治疗干预的患者。
  • 需进一步大规模、仅纳入手术治疗并按部位分层的研究以及纹理指数分析,以建立可靠的FDG-PET/CT预后模型。

研究设计与样本

  • 系统综述,检索PubMed/MEDLINE和ScienceDirect于2003年1月至2019年2月15日发表的英文文献。
  • 共检索到128项研究,36项符合纳入标准,包含3585例唯一患者,中位随访30.6个月(范围16-53个月)。
  • 纳入标准涉及口腔、口咽、下咽或喉癌,接受手术(原发或挽救),治疗前FDG-PET/CT,定量或半定量评估参数,以及参数值与临床结局的关联。
  • 使用牛津循证医学中心证据级别进行质量评估。

主要发现

  • 36项研究中32项显示至少1个FDG-PET/CT参数与肿瘤学结局(OS、DFS和DM)相关。
  • 在OS的单变量分析中,SUVmax与OS相关见于11项研究中的5项,MTV见于12项中的11项,TLG见于9项中的6项。
  • FDG-PET/CT体积参数(MTV和TLG)在多数数据中为独立预后因素,预后价值高于SUVmax。
  • 通过纹理指数评估的代谢空间分布似乎有前景,但目前评估不足:仅3项研究分析了放射组学指数的数据。

临床怎么用

  • 术前FDG-PET/CT的MTV和TLG可能用于识别术后疾病进展高风险的HNSCC患者,以考虑早期治疗干预。
  • SUVmax的预后价值相对较低,体积参数可能更受关注。
  • 纹理指数和放射组学指标目前证据有限,暂不宜常规用于临床决策。

局限性

  • 仅纳入英文文献,可能存在语言偏倚。
  • 纳入研究异质性较大,未按肿瘤部位分层分析。
  • 放射组学纹理指数分析研究数量很少(仅3项),证据不足。
  • 需进一步大规模、仅纳入手术治疗患者并按部位分层的研究来定义可靠的预后模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Head and neck squamous cell cancer (HNSCC) represents the seventh most frequent cancer worldwide. More than half of the patients diagnosed with HNSCC are treated with primary surgery. OBJECTIVE: To report the available evidence on the value of quantitative parameters of fluorodeoxyglucose F 18-labeled positron emission tomography and computed tomography (FDG-PET/CT) performed before surgical treatment of HNSCC to estimate overall survival (OS), disease-free survival (DFS), and distant metastasis (DM) and to discuss their limitations. EVIDENCE REVIEW: A systematic review of the English-language literature in PubMed/MEDLINE and ScienceDirect published between January 2003 and February 15, 2019, was performed between March 1 and July 27, 2019, to identify articles addressing the association between preoperative FDG-PET/CT parameters and oncological outcomes among patients with HNSCC. Articles included those that addressed the following: (1) cancer of the oral cavity, oropharynx, hypopharynx, or larynx; (2) surgically treated (primary or for salvage); (3) pretreatment FDG-PET/CT; (4) quantitative or semiquantitative evaluation of the FDG-PET/CT parameters; and (5) the association between the value of FDG-PET/CT parameters and clinical outcomes. Quality assessment was performed using the Oxford Centre for Evidence-Based Medicine level of evidence. FINDINGS: A total of 128 studies were retrieved from the databases, and 36 studies met the inclusion criteria; these studies comprised 3585 unique patients with a median follow-up of 30.6 months (range, 16-53 months). Of these 36 studies, 32 showed an association between at least 1 FDG-PET/CT parameter and oncological outcomes (OS, DFS, and DM). The FDG-PET/CT volumetric parameters (metabolic tumor volume [MTV] and total lesion glycolysis [TLG]) were independent prognostic factors in most of the data, with a higher prognostic value than the maximum standard uptake value (SUVmax). For example, in univariate analysis of OS, the SUVmax was correlated with OS in 5 of 11 studies, MTV in 11 of 12 studies, and TLG in 6 of 9 studies. The spatial distribution of metabolism via textural indices seemed promising, although that factor is currently poorly evaluated: only 3 studies analyzed data from radiomics indices. CONCLUSIONS AND RELEVANCE: The findings of this study suggest that the prognostic effectiveness of FDG-PET/CT parameters as biomarkers of OS, DFS, and DM among patients with HNSCC treated with surgery may be valuable. The volumetric parameters (MTV and TLG) seemed relevant for identifying patients with a higher risk of postsurgical disease progression who could receive early therapeutic intervention to improve their prognosis. However, further large-scale studies including exclusively surgery-treated patients stratified according to localization and further analysis of the textural indices are required to define a reliable FDG-PET/CT-based prognostic model of mortality and recurrence risk for these patients.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Creff G, Devillers A, Depeursinge A, et al. Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32215611. doi:10.1001/jamaoto.2020.0014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。